SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-006134
Filing Date
2020-05-15
Accepted
2020-05-15 20:55:40
Documents
1
Period of Report
2020-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3880
  Complete submission text file 0001179110-20-006134.txt   5221
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UROVANT SCIENCES, INC. 5281 CALIFORNIA AVENUE, SUITE 100 IRVINE CA 92617
Business Address
Katkin Keith (Reporting) CIK: 0001314596 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 20887526